By Maria Cheng | AP Medical Writer
Vous n'êtes pas connecté
The UK's medicines regulator has approved a drug that's been shown to slow the progression of Alzheimer's disease, but the government likely won't pay for it.
By Maria Cheng | AP Medical Writer
A recent study from the University of Bristol has uncovered a promising new method to slow the progression of diabetic kidney disease, a condition...
THE European Medicines Agency (EMA) has ruled out banning or bringing in tougher restrictions on controversial painkiller Nolotil – for now. The...
THE European Medicines Agency (EMA) has ruled out banning or bringing in tougher restrictions on controversial painkiller Nolotil – for now. The...
A new report has revealed for the first time the wide-ranging and increasing health dangers posed by long-term weather extremes in the UK, as the...
Mpox is not COVID-19, but that pandemic’s bitter lessons have not all been learnt. By Peter Fabricius An ominous sense of déjà vu is...
Donald Trump's insistence on attaching a voter identification law onto a House funding bill is putting speaker Mike Johnson – and the Republican...
Donald Trump's insistence on attaching a voter identification law onto a House funding bill is putting speaker Mike Johnson – and the Republican...
The ZetaTalk Newsletter MonkeyPoxMonkey Pox or MPox as it is also called has been endemic in Africa for eons, and occasionally escapes Africa to be...
New research has found a way to diagnose Alzheimer’s disease (AD) earlier by analyzing biomarkers in blood. This could help reduce the effects of...